A large-scale outbreak of Mycoplasma pneumoniae infections was reported in Marseille, France, from 2023–2024, involving 218 cases (0.8% of 26,449 tested patients). The virus primarily affects children ≤15 years of age, with a significant increase in cases compared to previous years. The outbreak was associated with a high prevalence of co-infections with other respiratory viruses, such as rhinovirus, influenza A, and respiratory syncytial virus. The median age of infected patients was lower in 2023–2024 than in previous years, and the population affected shifted to include more adults, possibly due to transmission from infected children. The study highlights the importance of syndromic diagnostic strategies for detecting co-infections. The outbreak aligns with global trends of increased M. pneumoniae cases following the COVID-19 pandemic. The study also notes the need for further research into the role of asymptomatic carriers and the complex interactions between co-detected pathogens in respiratory infections. The findings suggest that M. pneumoniae may be re-emerging due to factors such as reduced immunity or the emergence of new strains. The study emphasizes the importance of monitoring and controlling M. pneumoniae infections, particularly in vulnerable populations. The results are consistent with surveillance data from France and Europe, indicating a delayed resurgence of the virus after pandemic restrictions. The study also highlights the need for improved diagnostic methods and public health strategies to address the increasing prevalence of M. pneumoniae infections.A large-scale outbreak of Mycoplasma pneumoniae infections was reported in Marseille, France, from 2023–2024, involving 218 cases (0.8% of 26,449 tested patients). The virus primarily affects children ≤15 years of age, with a significant increase in cases compared to previous years. The outbreak was associated with a high prevalence of co-infections with other respiratory viruses, such as rhinovirus, influenza A, and respiratory syncytial virus. The median age of infected patients was lower in 2023–2024 than in previous years, and the population affected shifted to include more adults, possibly due to transmission from infected children. The study highlights the importance of syndromic diagnostic strategies for detecting co-infections. The outbreak aligns with global trends of increased M. pneumoniae cases following the COVID-19 pandemic. The study also notes the need for further research into the role of asymptomatic carriers and the complex interactions between co-detected pathogens in respiratory infections. The findings suggest that M. pneumoniae may be re-emerging due to factors such as reduced immunity or the emergence of new strains. The study emphasizes the importance of monitoring and controlling M. pneumoniae infections, particularly in vulnerable populations. The results are consistent with surveillance data from France and Europe, indicating a delayed resurgence of the virus after pandemic restrictions. The study also highlights the need for improved diagnostic methods and public health strategies to address the increasing prevalence of M. pneumoniae infections.